Stevens Johnson Syndrome: Past, Present, and Future Directions Gynecologic Manifestations and Management in SJS/TEN

Stevens Johnson Syndrome: Past, Present, and Future Directions Gynecologic Manifestations and Management in SJS/TEN

Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are severe mucocutaneous hypersensitivity disorders characterized by sudden onset epidermal necrosis. Acute manifestations of SJS/TEN often include vulvovaginal erosions, ulcerations, vaginal discharge, bleeding, vaginal pain, dysur...

Full description

Bibliographic Details
Main Authors:	Michelle A. DenAdel, Sarah E. Hendrickson, Esther Fuchs
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Medicine
Subjects:	Stevens Johnson Syndrome (SJS) Toxic Epidermal Necrolysis (TEN) vulvovaginal sequelae gynecologic manifestations of SJS/TEN treatment of vulva and vagina standardized protocol for SJS/TEN
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.874445/full

Similar Items

Steven-Johnson Syndrome
by: Pauline Joy F. Santos, et al.
Published: (2017-07-01)

Disease severity and status in Stevens–Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs
by: Rannakoe J. Lehloenya, et al.
Published: (2022-09-01)

Clinicoetiological study of Stevens-Johnson syndrome and toxic epidermal necrolysis spectrum and the correlation of SCORTEN with prognosis
by: Amuthavalli Kanagarajan, et al.
Published: (2023-01-01)

Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review
by: Ajay N. Sharma, BS, et al.
Published: (2020-09-01)

Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients
by: Perwitasari DA, et al.
Published: (2021-02-01)

The successful management of SJS/TEN secondary to enfortumab vedotin therapy
by: Rhea Singh, BS, et al.
Published: (2022-06-01)

Scoring Assessments in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Allison S. Dobry, et al.
Published: (2022-06-01)

An alternative model for assessing mortality risk in Stevens Johnson syndrome/toxic epidermal necrolysis using a random forests classifier: A pilot study
by: Omar Shareef, et al.
Published: (2022-12-01)

Findings by an International Collaboration on SJS/TEN With Severe Ocular Complications
by: Mayumi Ueta
Published: (2021-12-01)

A meta-analysis of cyclosporine treatment for Stevens–Johnson syndrome/toxic epidermal necrolysis
by: Ng QX, et al.
Published: (2018-03-01)

Editorial: Stevens Johnson syndrome: past, present, and future directions
by: Hajirah N. Saeed, et al.
Published: (2024-03-01)

Diclofenac-Serratiopeptidase Combination Induced Stevens – Johnson Syndrome - A Rare Case Report with Review of Literature
by: Saibal Moitra, et al.
Published: (2014-07-01)

Increased predisposition of sjs ten in COVID-19 patients, presenting as post COVID complication: Report of two cases
by: Shayna Aulakh, et al.
Published: (2022-01-01)

Altered levels of complement components associated with non-immediate drug hypersensitivity reactions
by: Feng Wang, et al.
Published: (2020-01-01)

ASSOCIATION BETWEEN CARBAMAZEPINE INDUCED SEVERE CUTANEOUS ADVERSE DRUG REACTION AND HLA POLIMORPHISMS
by: Safrina Dewi Ratnaningrum
Published: (2016-01-01)

Severe ocular complications of SJS/TEN and associations among pre-onset, acute, and chronic factors: a report from the international ophthalmology collaborative group
by: Mayumi Ueta, et al.
Published: (2023-06-01)

SJS/TEN immune-related dermatologic reaction secondary to immune checkpoint inhibitor pembrolizumab in skin of color
by: A.B. Pierre, et al.
Published: (2023-12-01)

Causes of Drug-Induced Severe Cutaneous Adverse Reaction Epidermal Necrolysis (EN): An Analysis Using FDA Adverse Event Reporting System (FAERS) Database
by: Fei W, et al.
Published: (2023-08-01)

Successful Treatment of Carbamazepine-Induced Toxic Epidermal Necrolysis With Clinical Gastrointestinal Involvement: A Case Report
by: Le Quynh Chi, et al.
Published: (2022-04-01)

Oral mucosal Myiasis: A rare association with pediatric SJS-TEN overlap
by: Annie Raizada, et al.
Published: (2021-01-01)

Anesthetic management and outcomes of patients with Steven-Johnson Syndrome—A retrospective review study
by: Manjula V Ramsali, et al.
Published: (2021-01-01)

Analysis of adverse reactions with phenytoin and carbamazepine in tertiary care hospital – A retrospective study
by: Syed Arshaduddin Ahmed1 , Mohammed Abid Ali2 , T S Usha Sree3 , Margaret Viola4 , Shaima Zafer Khan 5
Published: (2019-04-01)

Severe Cutaneous Adverse Drug Reaction
by: Damayanti Damayanti, et al.
Published: (2017-08-01)

Severe Cutaneous Adverse Reactions Associated With High-Dose Lamotrigine for Mood Disorders: A Case Series
by: Abigale Clark, et al.
Published: (2022-07-01)

Ivermectin induced Steven–Johnsons syndrome: case report
by: Desmond Aroke, et al.
Published: (2017-05-01)

Analysis of severity and preventability in patients of—Toxic epidermal necrolysis—A case series
by: Deepa Latha Ciddhavaduta, et al.
Published: (2020-12-01)

Visual function and quality of life in patients with Stevens-Johnson syndrome who received acute protocol-based ocular care
by: Swapna S. Shanbhag, et al.
Published: (2022-11-01)

Acute and Chronic Management of Ocular Disease in Stevens Johnson Syndrome/Toxic Epidermal Necrolysis in the USA
by: Derek Metcalfe, et al.
Published: (2021-07-01)

Case report: Alpelisib-induced Stevens–Johnson syndrome
by: Christine Jane Kurian, et al.
Published: (2022-09-01)

CASE REPORT BLEPHAROCONJUNCTIVITIS AS MANIFESTATION OF STEVENSJOHNSON SYNDROME
by: Putu Ayu Adindhya Saraswati Surya, et al.
Published: (2021-09-01)

Role of amniotic membrane transplantation in treating acute ocular manifestations in Steven–Johnson syndrome and its long-term impact
by: Prabhakar Singh, et al.
Published: (2022-01-01)

Reactive infectious mucocutaneous eruption secondary to SARS‐CoV‐2 and influenza A coinfection with varicella zoster virus reactivation
by: Aref Moshayedi, et al.
Published: (2023-09-01)

A case of drug‐induced Stevens‐Johnson syndrome‐like eruption predominating in mucosa: A case report
by: Akihiro Ishiguro, et al.
Published: (2020-08-01)

Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction
by: Paul V. Viscuse, et al.
Published: (2021-03-01)

Categorization of the Ocular Microbiome in Japanese Stevens–Johnson Syndrome Patients With Severe Ocular Complications
by: Mayumi Ueta, et al.
Published: (2021-11-01)

Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactions
by: S. Veenstra, et al.
Published: (2023-08-01)

Negative Response of Lymphocyte Transformation Test (LTT) in a Patient Diagnosed as Stevens-Johnson Syndrome: A Case Report
by: Ryski Meilia Novarina, et al.
Published: (2016-03-01)

High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer
by: Alyce M. Kuo, et al.
Published: (2022-06-01)

AGEP overlap induced by hydroxychloroquine: a case report and literature review
by: Christopher Mercogliano, et al.
Published: (2018-11-01)

Toxic Epidermal Necrolysis
by: Syed Naveed Ali Shah, et al.
Published: (2020-11-01)